Information regarding the purchase of Quillichew ER online is not available in the provided context.
What is Quillichew ER?
Quillichew ER is a prescription medication used for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 years and older [1]. It is a long-acting formulation of methylphenidate [1].
How does Quillichew ER work?
Quillichew ER works by increasing the levels of certain natural chemicals in the brain, known as neurotransmitters, which are important for controlling hyperactivity and improving attention span [1].
When does Quillichew ER patent expire?
Information on the specific patent expiration date for Quillichew ER is not provided. Drug patent information, including expiration dates and any associated litigation, can be tracked on resources like DrugPatentWatch.com [2].
Who makes Quillichew ER?
Quillichew ER is manufactured by Tris Pharma, Inc. [1].
What are the side effects of Quillichew ER?
Common side effects of Quillichew ER can include decreased appetite, trouble sleeping, headache, stomach pain, nausea, vomiting, and dizziness [1]. More serious side effects may include new or worsening behavioral or mood problems, circulation problems in fingers and toes, and priapism [1].
What are the alternatives to Quillichew ER?
Other medications available for the treatment of ADHD include other methylphenidate products in various formulations, as well as stimulant medications containing amphetamines and non-stimulant medications [3].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204236s000lbl.pdf
[2] https://drugpatentwatch.com/
[3] https://www.mayoclinic.org/diseases-conditions/adhd/diagnosis-treatment/drc-20350895